Patents by Inventor John Frederick Seager

John Frederick Seager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline complexes of fluticasone-2-furoate
    Patent number: 7592329
    Abstract: There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in that the crystalline complex is of space group P212121 having unit cell dimensions of about 12.5±1.0 §, 15±1.0 §, and 16.2±1.0 § when determined at either 120K or 150K.
    Type: Grant
    Filed: February 4, 2003
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Andrew Craig, David Malcolm Crowe, Victor Witold Jacewicz, Michael John Millan, Rosalyn Kay Nice, Brian Noga, John Frederick Seager, Andrew Lewis Theophilus
  • Carbocyclic nucleoside hemisulfate and its use in treating viral infections
    Patent number: 6294540
    Abstract: The hemisulfate salt of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol or a solvate of it is used in the treatment of viral infections.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: September 25, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Alastair Couper Brodie, Martin Francis Jones, John Frederick Seager, Christopher John Wallis